FDA Medical Disclaimer
Overview
This FDA Medical Disclaimer provides important information about the use, approval status, and preparation of medications discussed or prescribed through Med Matrix. The purpose of this statement is to ensure transparency and regulatory compliance with applicable FDA guidelines and federal law.
FDA Approval Status
Certain FDA-approved products that contain active ingredients such as Semaglutide (Wegovy®, Ozempic®, Rybelsus®) and Liraglutide (Saxenda®) have been reviewed and approved by the U.S. Food and Drug Administration (FDA) for specific medical uses.
When prescribed in compounded form, these medications are not individually reviewed or approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Compounded formulations may be prescribed when an FDA-approved product is unavailable or clinically unsuitable for a specific patient’s needs.
Use of Compounded Medications
At Med Matrix, compounded medications are used only when medically necessary and when FDA-approved options cannot adequately address a patient’s condition or availability.
All compounded prescriptions provided through Med Matrix are:
- Prepared by state-licensed compounding pharmacies, 
- Prescribed by qualified healthcare professionals, and 
- Monitored under professional medical supervision to ensure safety and efficacy. 
Medical Advice Disclaimer
All information provided on the Med Matrix website, including educational materials, treatment descriptions, and patient resources, is for informational purposes only and should not be considered medical advice.
Always seek the advice of a licensed healthcare provider before starting, changing, or discontinuing any medication or treatment. Never disregard professional medical advice because of information you have read on this website.
No FDA Endorsement
The mention of specific medications, compounds, or therapies on this site does not imply endorsement by the U.S. Food and Drug Administration (FDA). The FDA has not evaluated any statements or products mentioned on this website unless explicitly stated otherwise.
Reporting Adverse Events
Patients are encouraged to report any side effects or adverse reactions from compounded medications to:
- Their prescribing healthcare provider, and 
- The FDA MedWatch Program at www.fda.gov/medwatch. 
Contact Information
For questions about this disclaimer or to request additional information, please contact:
Med Matrix
South Portland, Maine
privacy@medmatrixusa.com
207-544-4643